Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aromatase Inhibitor”

466 trials

Showing 20 of 466 results

Testing effectiveness (Phase 2)Looking for participantsNCT03624244
What this trial is testing

Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)

Who this might be right for
Low Grade Endometrial Stromal Sarcoma
Centre Leon Berard 40
Large-scale testing (Phase 3)Ended earlyNCT02532400
What this trial is testing

Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients

Who this might be right for
Breast Cancer
Ruijin Hospital 21
Not applicableStudy completedNCT00767585
What this trial is testing

An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily Practice

Who this might be right for
Breast CancerOsteoporosis
AstraZeneca 560
Large-scale testing (Phase 3)Active Not RecruitingNCT02246621
What this trial is testing

Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Eli Lilly and Company 493
Early research (Phase 1)Study completedNCT00100893
What this trial is testing

IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 37
Not applicableStudy completedNCT00784888
What this trial is testing

Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy

Who this might be right for
Breast Neoplasms
Pfizer 344
Early research (Phase 1)Study completedNCT00508586
What this trial is testing

PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
PTC Therapeutics 33
Not applicableStudy completedNCT03786198
What this trial is testing

Activity Program During Aromatase Inhibitor Therapy

Who this might be right for
Early Breast Cancer
Swiss Cancer Institute 375
Testing effectiveness (Phase 2)WithdrawnNCT01814865
What this trial is testing

Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer

Who this might be right for
Post-menopausal ER+ Stage I-IIIA Primary Operable Breast Cancer
British Columbia Cancer Agency
Testing effectiveness (Phase 2)Ended earlyNCT01484041
What this trial is testing

Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Georgetown University 12
Not applicableStudy completedNCT02548637
What this trial is testing

Effects of Acupuncture on Aromatase Inhibitor-Induced Joint Pain

Who this might be right for
Breast Cancer
Saint John's Cancer Institute 20
Post-approval studies (Phase 4)Study completedNCT00286364
What this trial is testing

Short-Term Androgen Priming Before COS Using Aromatase Inhibitor and hCG During Early-Follicular-Phase GnRH Antagonist Administration - a Randomized Controlled Trial

Who this might be right for
Infertility
Rigshospitalet, Denmark
Not applicableStudy completedNCT00516698
What this trial is testing

Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 140
Testing effectiveness (Phase 2)UnknownNCT02530411
What this trial is testing

Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancer

Who this might be right for
Neoplasms
Velindre NHS Trust 160
Not applicableStudy completedNCT03898947
What this trial is testing

Endometrial Changes in Breast Cancer Women With or Without Hormonal Therapies

Who this might be right for
Breast CancerEndometrial Cancer
Università degli Studi dell'Insubria 1,329
Testing effectiveness (Phase 2)Study completedNCT00754325
What this trial is testing

Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor

Who this might be right for
Advanced Breast Cancer
Bristol-Myers Squibb 100
Not applicableStudy completedNCT03447184
What this trial is testing

Long-term Endogenous Androgen Priming in Bologna Criteria Poor Responder Patients - A Pilot Study

Who this might be right for
Poor Ovarian Response
Mỹ Đức Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01298713
What this trial is testing

Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer

Who this might be right for
Breast NeoplasmsmTor Protein
ARCAGY/ GINECO GROUP 111
Not applicableUnknownNCT01793038
What this trial is testing

Clomiphene Citrate Plus uFSH Versus Aromatase Inhibitor Plus uFSH in Clomiphene Resistant Infertile PCOS Women

Who this might be right for
Polycystic Ovary SyndromeInfertility
Mansoura Integrated Fertility Center 160
Not applicableStudy completedNCT00968214
What this trial is testing

Study of Tumor and Blood Samples From Postmenopausal Women With Primary Breast Cancer Enrolled on Clinical Trial CAN-NCIC-MA27

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 364
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation